selected scholarly activity
-
conferences
- Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.. Journal of Clinical Oncology. 332-332. 2022
- Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.. Journal of Clinical Oncology. E18628-E18628. 2022
- Abstract P5-20-17: Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. p5-20-17-p5-20-17. 2018
- Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study. Cancer Research. 2018
- Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.. Journal of Clinical Oncology. e12030-e12030. 2017
-
journal articles
- First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.. Journal of Clinical Oncology. JCO2401326. 2024
- Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.. Journal of Clinical Oncology. 40:332-332. 2022
- Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.. Journal of Clinical Oncology. 40:e18628-e18628. 2022
- A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre. Gynecologic Oncology. 161:236-243. 2021
- Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?. Oncologist. 24:1405-1409. 2019
- Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity. JACC: CardioOncology. 1:1-10. 2019
- An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction. Current Oncology. 26:240-246. 2019
- Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis. Radiotherapy and Oncology. 134:55-66. 2019
- Clinical Practice Guidelines in Breast Cancer. Current Oncology. 25:151-160. 2018
- The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding. American Journal of Hematology. 93:E42-E45. 2018
- Reasons and Outcomes for Long‐Term Care Transfers to the Hospital: A Retrospective Review. Journal of The American Geriatrics Society. 62:577-578. 2014